Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Molecular Cancer Therapeutics
|
October 8, 2009
In vivo effects of targeting CD79b with antibodies and antibody-drug conjugates
Bing Zheng, Reina N Fuji, Kristi Elkins, et al.
The Journal of Antimicrobial Chemotherapy
|
August 28, 2020
Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda
Emmanuel Ndashimye, Mariano Avino, Abayomi S Olabode, et al.
Nature
|
December 22, 2006
Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis
John Ridgway, Gu Zhang, Yan Wu, et al.
Cancer Research
|
May 1, 2002
Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate
Sarajane Ross, Susan D Spencer, Ilona Holcomb, et al.
Nature
|
December 25, 2015
Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell function
Elaine E Storm, Steffen Durinck, Felipe de Sousa e Melo, et al.
Blood
|
March 22, 2007
Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma
Andrew G Polson, Shang-Fan Yu, Kristi Elkins, et al.
Neuron
|
December 22, 2015
Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies
Y Joy Yu Zuchero, Xiaocheng Chen, Nga Bien-Ly, et al.
Science Translational Medicine
|
November 8, 2014
Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
Y Joy Yu, Jasvinder K Atwal, Yin Zhang, et al.
Molecular Cancer Therapeutics
|
September 16, 2008
Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake
Yonglei Shang, Yifan Mao, Jennifer Batson, et al.
Cell
|
April 8, 2010
PlGF blockade does not inhibit angiogenesis during primary tumor growth
Carlos Bais, Xiumin Wu, Jenny Yao, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Molecular Cancer Therapeutics
|
October 8, 2009
In vivo effects of targeting CD79b with antibodies and antibody-drug conjugates
Bing Zheng, Reina N Fuji, Kristi Elkins, et al.
The Journal of Antimicrobial Chemotherapy
|
August 28, 2020
Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda
Emmanuel Ndashimye, Mariano Avino, Abayomi S Olabode, et al.
Nature
|
December 22, 2006
Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis
John Ridgway, Gu Zhang, Yan Wu, et al.
Cancer Research
|
May 1, 2002
Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate
Sarajane Ross, Susan D Spencer, Ilona Holcomb, et al.
Nature
|
December 25, 2015
Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell function
Elaine E Storm, Steffen Durinck, Felipe de Sousa e Melo, et al.
Blood
|
March 22, 2007
Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma
Andrew G Polson, Shang-Fan Yu, Kristi Elkins, et al.
Neuron
|
December 22, 2015
Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies
Y Joy Yu Zuchero, Xiaocheng Chen, Nga Bien-Ly, et al.
Science Translational Medicine
|
November 8, 2014
Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
Y Joy Yu, Jasvinder K Atwal, Yin Zhang, et al.
Molecular Cancer Therapeutics
|
September 16, 2008
Antixenograft tumor activity of a humanized anti-insulin-like growth factor-I receptor monoclonal antibody is associated with decreased AKT activation and glucose uptake
Yonglei Shang, Yifan Mao, Jennifer Batson, et al.
Cell
|
April 8, 2010
PlGF blockade does not inhibit angiogenesis during primary tumor growth
Carlos Bais, Xiumin Wu, Jenny Yao, et al.
Page
of 3